kangcs

kangcs | Joined since 2014-07-31

Investing Experience -
Risk Profile -

Followers

1

Following

0

Blog Posts

0

Threads

780

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
780
Past 30 days
11
Past 7 days
3
Today
0

User Comments
Stock

2020-08-27 14:48 | Report Abuse

Have to wait the BIG NEWS which will release

Stock

2020-08-26 17:39 | Report Abuse

hope that the BIG NEWS can bring the price higher

Stock

2020-08-26 17:01 | Report Abuse

Big Shark is still collecting at 6c
1 more news going to release

Stock

2020-08-25 16:45 | Report Abuse

BIG SHARK Banyak keep 6c

Stock

2020-08-25 14:27 | Report Abuse

Macam mau moving up

Stock

2020-08-25 12:12 | Report Abuse

Some big news going to release, share will fly

Stock

2020-08-25 11:06 | Report Abuse

SOMETHING GOING TO HAPPENS SOON

Stock

2020-08-25 11:01 | Report Abuse

BIG SHARK STILL ACCUMULATING AT 6 SEN

Stock

2020-08-19 10:57 | Report Abuse

See...what taktik tu BIGSHARK main ni

Stock

2020-08-19 10:50 | Report Abuse

As long as got high volume, then it's ok..will shooting UP

Stock

2020-08-19 10:34 | Report Abuse

Looks like some one control the price not to break 0.065sen

Stock

2020-08-19 09:42 | Report Abuse

Latest Developments
More
2 days ago
Nexgram Holdings Says Unit Enters Unincorporated JVA With Faldze Holdings

6 days ago
Nexgram Says Unit Entered MoU With Arita Holdings

a month ago
Nexgram Holdings Says Unit Enters Conditional Offtake & Purchase Agreement With PT Mitra Abadi Propertindo Utama

Stock

2020-08-19 09:42 | Report Abuse

EXECUTIVE LEADERSHIP

Rusli Bin Ahmad

Independent Non-Executive Chairman of the Board

Siew Lee Yek

Managing Director, Executive Director

Mazru bin Mat Yusof

Group Financial Controller, Executive Director

Youn Kim Wong

Company Secretary

Lit Fung Fu

Non-Independent Non-Executive Director

Stock

2020-08-19 08:37 | Report Abuse

Hari ini pasti UP

Stock

2020-08-18 15:01 | Report Abuse

Going to shooting up...Shark punya bullet da cukup

Stock
Stock

2020-08-14 16:29 | Report Abuse

Listing Date 17-Aug-2020
New type/class? No
Type Conversion of Preference Shares
Details Conversion of Irredeemable Convertible Preference Shares ("ICPS") to Ordinary Shares
No. of shares issued 300,000,000
Issue Price Malaysian Ringgit (MYR) 0.020
Par Value - 0.000
Total NOSH 2,661,204,480

Stock

2020-08-13 14:47 | Report Abuse

someone collecting big amount in 0.065

Stock

2020-08-13 12:06 | Report Abuse

Avg Vol853.66
Value4.298m
Trans774
Buy Rate64%Trend
Prv Close Price0.060
T-Price0.065
Open Price0.065
High Price0.070
Low Price0.060

Stock

2020-08-13 11:29 | Report Abuse

the Big Sharks is collecting @0.065

Stock

2020-08-12 14:00 | Report Abuse

https://nexgram.co/category/press-release/

Recent Posts
Glove Alliance 1.2 billion nitrile gloves supplies a year is open for tender [28 July 2020]
Nexgram and Malaysian Tourism Council enrol Tracvirus Covid-19 Test for 3.5 million workers [23 July 2020] Press Release
Nexgram bag medical Nitrile Examination Gloves contract to supply Indonesia [23 July 2020]
Nexgram Biomedic venture into COVID-19 molecular diagnostic and vaccine research & development [5 June 2020]
BRIEF-Nexgram Holdings Says Unit Entered Sales Agreement With Shanghai Liangrun Biomedicine Technology Co – Reuters [27 May 2020]

Stock

2020-08-12 10:59 | Report Abuse

if this afternoon got good announcement then HUAT ah

Stock
Stock
Stock

2020-08-12 08:59 | Report Abuse

buka 7sen ...kena kao kao punya power to shoot up la

Stock

2020-08-11 17:39 | Report Abuse

Big shark collected at 7sen....will fly fly fly

Stock

2020-08-11 15:12 | Report Abuse

MACAM MAU RUN LOL

Stock
Stock

2020-08-11 09:04 | Report Abuse

GOOD OPENING... :)

Stock
Stock

2020-08-10 10:02 | Report Abuse

Rasa OZURA tu buang share balance lahi

Stock

2020-08-10 09:07 | Report Abuse

MARI MARI MARI...GO) GO GO

Stock

2020-08-07 11:29 | Report Abuse

其中三种来自中国

Press: Shanghai Liangrun Biomedicine Technology co., Ltd Covid-19 Test Kid arrived Malaysia [18 May 2020]

Stock

2020-08-07 11:28 | Report Abuse

央视新闻8月7日消息,当地时间8月6日,世卫组织召开新冠肺炎例行发布会,世卫组织卫生紧急项目负责人迈克尔·瑞安表示,目前全球约有165种疫苗处于试验阶段,26种进入临床试验阶段,六种已处于三期临床试验阶段,其中三种来自中国,短期内取得如此成果是难以置信的。接下来就是要确保疫苗安全有效,三期临床试验将展开大规模测试,世卫组织希望将有更多候选疫苗进入三期临床试验阶段。

Stock
Stock

2020-08-06 11:30 | Report Abuse

sabar..soon our turn

Stock

2020-08-06 08:44 | Report Abuse

Bangun Bangun...

Stock

2020-08-04 17:26 | Report Abuse

Banyak lagi balance...

Circumstances by reason of which change has occurred Disposal of Shares
Nature of interest Direct Interest
Direct (units) 162,000,000
Direct (%) 6.868
Indirect/deemed interest (units) 0
Indirect/deemed interest (%) 0
Total no of securities after change 162,000,000
Date of notice 04 Aug 2020

Stock

2020-08-04 17:19 | Report Abuse

itu jual masa 29 July...

Stock

2020-08-04 17:18 | Report Abuse

No Date of change
No of securities
Type of Transaction Nature of Interest
1 29 Jul 2020
45,000,000
Disposed Direct Interest
Name of registered holder OZURA FIRSTLOGIX SDN BHD
Address of registered holder 1-47, Jalan SP2 Taman Segar Perdana 43200 Cheras Selangor

Stock

2020-08-04 13:42 | Report Abuse

Glove Alliance 1.2 billion nitrile gloves supplies a year is open for tender [28 July 2020]
logos328 July 2020, Kuala Lumpur, Malaysia – Malaysia glove company Glove Alliance Sdn Bhd offers wholesale buyers monthly and long-term glove contracts through strategic contract manufacturing and bulk purchase arrangement.

The company is part of Nexgram Biomedic Sdn Bhd, the subsidiary of Malaysia public listed company Nexgram Holdings Bhd.

According to company website, Glove Alliance contract manufacturing helps glove companies expand capacity with an off-take order.

The company provides business advisories and strategic joint venture and alliances to small and medium size glove companies or manufacturers to expand production capacity and secure International wholesale bulk contracts, together with trade financing and facilities.

The company secured partner manufacturers’ plants, machineries, and stocks for financing arrangement, and provide bulk orders to buyers ranging from 100,000 boxes per order, or 2,000,000 boxes per month, with 6, 12, 24 or 36 months contracts.

The company specialist also provides advisory for International standard certifications, including CE, FDA, ISO, and others, to ensure our factories supply quality products to our buyers.

Currently the company has 12 million boxes (or 1.2 billion pieces) of nitrile gloves a year capacity, and had recently secured contract of 500,000 boxes a month, for a period of 3 years, to supply Indonesia tender bidding through local wholesale distributor. The company through strategic alliances is expanding the capacity to 48 million boxes (or 4.8 billion pieces) of gloves a year by 4th quarter 2020.

Glove Alliance K-Gloves Nitrile Examination Gloves Powder-Free, is non-sterile, coral blue, nitrile butadiene rubber, beaded cuff, ambidextrous superior quality gloves, which came with S, M and L sizes. Besides nitrile gloves, the company has contract manufacturing capacity for 2 million pieces of medical Isolation Gown per month.



About Glove Alliance

Glove Alliance contract manufacturing helps glove companies expand capacity with an off-take order. The company provides business advisories and strategic joint venture and alliances to small and medium size glove companies or manufacturers to expand production capacity and secure International wholesale bulk contracts, together with trade financing and facilities. Visit glovealliance.com

Stock

2020-08-04 12:17 | Report Abuse

Someone collecting 6sen...bullet enough will; shoot up

Stock

2020-08-04 12:10 | Report Abuse

this afternoon will break 7sen...TP is much higher

Stock

2020-08-04 10:49 | Report Abuse

coming now...fly

Stock

2020-08-03 14:19 | Report Abuse

NEXGRAM (0096)
☆ Current Price : 0.055
☆ Suggest Price : 0.055
☆ Support 0.05
☆ Stop Loss : 0.045
☆ Resistance 0.07
** Disclaimers : Information and comments presented does not represent the opinion whether to buy, sell or hold shares of a particular stock. Information shared above shall be treated solely for educational purpose only. The author may have positions in some of these instruments. The author shall not be responsible for any losses or lost profit resulting from investment decisions based on the use of the information contained herein.

Stock